Author Details

Абрамов, М. Е

Issue Section Title File
No 1S (2009) Articles FOTEMUSTIN PRI DISSEMINIROVANNOY MELANOME KOZhI
No 8 (2013) Articles ASPEKTY PRIMENENIYa PEGFILGRASTIMA PRI PROVEDENII KhIMIOTERAPII PATsIENTOV S SOLIDNYMI OPUKhOLYaMI
No 8 (2013) Articles NOVYY IMMUNOMODULYaTOR REFNOT V LEChENII ONKOLOGIChESKIKh BOL'NYKh
No 17 (2013) Articles Refnot® – novyy immunomodulyator dlya lecheniya onkologicheskikh bol'nykh
No 8 (2014) Articles PALONOSETRON V PROFILAKTIKE TOShNOTY I RVOTY PRI PROVEDENII VYSOKO I UMERENNO EMETOGENNOY KhIMIOTERAPII
No 10 (2014) Articles PERSPEKTIVY PRIMENENIYa S-1 V LEChENII BOL'NYKh RAKOM ZhELUDKA
No 8 (2015) Articles Novye vozmozhnosti profilaktiki toshnoty i rvoty pri provedenii khimioterapii
No 8 (2015) Articles VLIYaNIE REFNOTA NA IMMUNITET U ONKOLOGIChESKIKh BOL'NYKh
No 18 (2015) Articles Sovremennye dostizheniya v lekarstvennoy terapii disseminirovannoy melanomy kozhi
No 18 (2015) Articles Sovremennye vozmozhnosti lecheniya anemii u bol'nykh s solidnymi opukholyami
No 8 (2016) Articles EFFICACY OF DABRAFENIB AND TRAMETINIB IN THE TREATMENT OF DISSEMINATED MELANOMA WITH BRAF MUTATION
No 17 (2016) Articles TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
No 17 (2016) Articles NEW REALITIES IN THE TREATMENT OF DISSEMINATED SKIN MELANOMA WITH BRAF MUTATION
No 17 (2016) Articles WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
No 17 (2016) Articles METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
No 8 (2017) Articles Long-term results of combined treatment of colorectal cancer patients with liver metastases
No 8 (2017) Articles Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
No 8 (2017) Articles Modern aspects of application of palonosetron during chemotherapy
No 17 (2017) Articles Olaparib - promising direction in therapy in BRCA-associated tumors
Vol 26, No 12 (2019) Articles The role of erythropoietin preparations in the treatment of anemia in oncologic patients

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies